Stock Market & Financial Investment News

News Breaks March 11, 2013 14:02 EDT ZTS Lazard Asset Management reports 8.48% passive stake in Zoetis News For ZTS From The Last 14 Days Check below for free stories on ZTS the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 24, 2013 05:59 EDT ZTS Zoetis implied volatility at upper end of index mean range Subscribe for More Information May 23, 2013 12:37 EDT ZTS Options with increasing implied volatility: UNXL ZTS EWJ SWI Subscribe for More Information 11:24 EDT ZTS High option volume stocks: ZTS AMLP CTAS MNKD CYS Subscribe for More Information May 22, 2013 11:50 EDT ZTS High option volume stocks: ZTS AIRM GLDD GTXI MNKD Subscribe for More Information 08:59 EDT ZTS On The Fly: Pre-market Movers Subscribe for More Information 08:06 EDT ZTS Zoetis comments on Pfizer’s split-off plans for remaining interest Subscribe for More Information 08:04 EDT ZTS Pfizer announces plan to split-off remainder of Zoetis Subscribe for More Information 08:02 EDT ZTS Pfizer announces plan to split-off remainder of Zoetis Subscribe for More Information May 16, 2013 08:06 EDT ZTS Zoetis' Apoquel for allergic dogs approved by FDA Zoetis announced that the FDA has approved Apoquel (oclacitinib tablet) for the control of pruritus associated with allergic dermatitis and the control of atopic dermatitis in dogs at least 12 months of age. Pruritus, or itching, is the most common sign of allergies in dogs. Sign up for a free trial to see the rest of the stories you've been missing.